HealthyDirect · GrowthFit for a long SIP
BANDHAN CRISIL IBX 90:10 SDL PLUS GILT - APRIL 2032 INDEX FUND
- NAV
- 13.197
- 5 Nov 2026
- 1Y
- +3.8%
- Trailing CAGR
- AUM
- ₹381.83 Cr
- 30 Sept 2026
- Volatility
- Low
- 2.1% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 5 Nov 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Watch
3.9 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.09% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -2.3%. Ask whether you can hold through a similar fall.
Vs category
Fail
6% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 66.6% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 2%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+3.8%
- 3Y+7.5%
- 5Yn/a
- 10Yn/a
- SI+7.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+3.7%
- 3Y+5.8%
- 5Yn/a
- 10Yn/a
- Since inception
- +7.3%
- Calendar-day CAGR
- Excess 1Y
- +3.2%
- Category median, same plan and option
- 3Y win rate
- +6%
- Windows beating the median
- 3Y percentile
- 51
- Vs comparable share classes
- SIP 3Y XIRR
- +5.8%
- Simulated monthly SIP
- Worst rolling 3Y
- +6.7%
- 231 daily-ending windows
- Median rolling 3Y
- +7.7%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -2.3%
- Worst peak-to-trough
- Current
- -1.1%
- Below last peak
- Current spell
- 87 days
- Days below latest peak
- Time below peak
- +71%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 6 days
- 109 recovered episodes
- Longest recovery
- 73 days
- Trough to prior peak
10 Aug 2026 – open
Trough 28 Oct 2026 · not recovered
-2.3%
4 Aug 2025 – 14 Nov 2025
Trough 2 Sept 2025 · recovered in 73 days
-2.3%
9 Mar 2026 – 9 Jun 2026
Trough 6 Apr 2026 · recovered in 64 days
-1.7%
3 Jun 2025 – 24 Jul 2025
Trough 30 Jun 2025 · recovered in 24 days
-1.0%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
51
Vs category
70
Consistency
23
Risk-adjusted
57
Drawdown
94
Mean
59
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 34 holdings · top 10 are 66.6%.
- Top 5
- 43.1%
- Top 10
- 66.6%
- Largest holding
- 12.9%
- Effective holdings
- 17.2
STATE DEVELOPMENT LOAN 31323 UP 25JN32 7.28 FV RS 100
Unspecified
12.9%
CENTRAL GOVERNMENT LOAN 31280 GOI 17JN32 6.54 FV RS 100
Entities
8.3%
STATE DEVELOPMENT LOAN 31497 TN 23MR32 7.23 FV RS 100
Unspecified
8.0%
7.73% Maharashta State Government Securities
Unspecified
7.4%
STATE DEVELOPMENT LOAN 32749 HAR 23MR32 7.72 FV RS 100
Unspecified
6.6%
What changed
DECISION
Status moved from HEALTHY to MONITOR.
8 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Nippon India Nifty SDL Plus G-Sec - Jun 2028 Maturity 70:30 Index Fund
Nippon India Mutual Fund
- 1Y
- +4.9%
- 3Y
- +7.5%
- Vol
- 1.1%
- Max DD
- -0.7%
- Sharpe
- 1.29
- 3Y win
- +16%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher TER
DSP Nifty SDL Plus G-Sec Sep 2027 50:50 Index Fund
DSP Mutual Fund
- 1Y
- +5.2%
- 3Y
- +7.5%
- Vol
- 0.9%
- Max DD
- -0.3%
- Sharpe
- 1.62
- 3Y win
- +6%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index Fund
Edelweiss Mutual Fund
- 1Y
- +5.5%
- 3Y
- n/a
- Vol
- 0.9%
- Max DD
- -0.5%
- Sharpe
- 1.51
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
Kotak CRISIL-IBX Financial Services 3-6 Months Debt Index Fund
Kotak Mahindra Mutual Fund
- 1Y
- +6.6%
- 3Y
- n/a
- Vol
- 0.4%
- Max DD
- -0.2%
- Sharpe
- 2.49
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
BANDHAN NIFTY 100 INDEX FUND
Bandhan Mutual Fund
- 1Y
- -2.2%
- 3Y
- +10.8%
- Vol
- 13.6%
- Max DD
- -17.3%
- Sharpe
- 0.36
- 3Y win
- +51%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER